Published in Health Risk Factor Week, April 8th, 2008
"The aim of this study was to investigate the effect of DC and ASA on NF-kappa B signaling, and determine its role in programmed cell death in a human gastric carcinoma cell line. Cells were incubated with DC in the presence or absence of ASA or proteasome inhibitors...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.